HU9602607D0 - New 1,4-disubstituted piperidine derivatives useful as medicaments acting on the glutamate receptor - Google Patents
New 1,4-disubstituted piperidine derivatives useful as medicaments acting on the glutamate receptorInfo
- Publication number
- HU9602607D0 HU9602607D0 HU9602607A HU9602607A HU9602607D0 HU 9602607 D0 HU9602607 D0 HU 9602607D0 HU 9602607 A HU9602607 A HU 9602607A HU 9602607 A HU9602607 A HU 9602607A HU 9602607 D0 HU9602607 D0 HU 9602607D0
- Authority
- HU
- Hungary
- Prior art keywords
- new
- glutamate receptor
- derivatives useful
- piperidine derivatives
- disubstituted piperidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Otolaryngology (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4410822A DE4410822A1 (en) | 1994-03-24 | 1994-03-24 | New piperidine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
HU9602607D0 true HU9602607D0 (en) | 1996-11-28 |
HUT75653A HUT75653A (en) | 1997-05-28 |
Family
ID=6514110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9602607A HUT75653A (en) | 1994-03-24 | 1995-03-23 | 1,4-disubstituted piperidine derivatives acting on the glutamate receptor process for producing them and pharmaceutical compositions containing the said compounds |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0751936A1 (en) |
JP (1) | JPH09510460A (en) |
KR (1) | KR970701695A (en) |
CN (1) | CN1145618A (en) |
AU (1) | AU2212595A (en) |
CA (1) | CA2186010A1 (en) |
CZ (1) | CZ277096A3 (en) |
DE (1) | DE4410822A1 (en) |
FI (1) | FI963786A0 (en) |
HU (1) | HUT75653A (en) |
IL (1) | IL113103A0 (en) |
NO (1) | NO963984L (en) |
PL (1) | PL316382A1 (en) |
SK (1) | SK120196A3 (en) |
WO (1) | WO1995025721A1 (en) |
ZA (1) | ZA952431B (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA9610736B (en) | 1995-12-22 | 1997-06-27 | Warner Lambert Co | 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists |
ZA9610745B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
ZA9610738B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | Subtype selective nmda receptor ligands and the use thereof |
ZA9610741B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
JP3248917B2 (en) * | 1996-03-08 | 2002-01-21 | エフ.ホフマン−ラ ロシュ アーゲー | Use of 4-phenyl-3,6-dihydro-2H-pyridyl derivatives as NMDA receptor subtype blockers |
US6017903A (en) | 1996-09-27 | 2000-01-25 | Guilford Pharmaceuticals Inc. | Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors |
US5824662A (en) | 1996-09-27 | 1998-10-20 | Guilford Pharmaceuticals Inc. | Treatment of global and focal ischemia using naaladase inhibitors |
PL332413A1 (en) | 1996-09-27 | 1999-09-13 | Guilford Pharm Inc | Compositions containing inhibitors of naaladase as well as methods of treating glutamatic anomaly and influencing neuronic functions among animals |
US6242450B1 (en) * | 1998-07-27 | 2001-06-05 | Eli Lilly And Company | 5-HT1F antagonists |
WO2000006158A1 (en) * | 1998-07-31 | 2000-02-10 | Eli Lilly And Company | Heterocyclyl sulphonamide derivatives |
CA2372715A1 (en) * | 1999-05-13 | 2001-04-12 | Shionogi & Co., Ltd. | Preventive or therapeutic drugs for diabetes |
TWI254043B (en) * | 1999-06-08 | 2006-05-01 | Hoffmann La Roche | Ethanesulfonyl-piperidine derivatives having good affinity to N-methyl-D-aspartate (NMDA) receptor |
ES2225330T3 (en) | 2000-03-22 | 2005-03-16 | Hoffmann La Roche | PIPERIDINE AND PIPERACINE COMPOSITE FOR USE IN THE TREATMENT OF ALZHEIMER. |
US6407235B1 (en) | 2000-08-21 | 2002-06-18 | Hoffmann-La Roche Inc. | Prodrug acid esters of [2-(4-benzyl-3-hydroxy-piperidin-1-yl)-ethansulfonyl]phenol |
US6770659B2 (en) * | 2002-08-26 | 2004-08-03 | Sk Corporation | Benzoyl piperidine compounds |
GB0224084D0 (en) | 2002-10-16 | 2002-11-27 | Glaxo Group Ltd | Novel compounds |
KR20240135687A (en) | 2017-06-20 | 2024-09-11 | 임브리아 파마슈티칼스, 인크. | Compositions and methods for increasing efficiency of cardiac metabolism |
CN110437136A (en) * | 2019-07-30 | 2019-11-12 | 东南大学 | 1- virtue oxygen ethyl piperidine -4- base methanone derivatives and its preparation method and application |
US11780811B2 (en) | 2020-06-30 | 2023-10-10 | Imbria Pharmaceuticals, Inc. | Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate |
US11530184B2 (en) | 2020-06-30 | 2022-12-20 | Imbria Pharmaceuticals, Inc. | Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate |
US11883396B2 (en) | 2021-05-03 | 2024-01-30 | Imbria Pharmaceuticals, Inc. | Methods of treating kidney conditions using modified forms of trimetazidine |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3576810A (en) * | 1968-06-20 | 1971-04-27 | Robins Co Inc A H | 1-substituted-3-(-4)-aroylpiperidines |
DE2827566A1 (en) * | 1978-06-23 | 1980-01-10 | Boehringer Mannheim Gmbh | 1,2-DIHYDRO-CHINOLIN-2-ON DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF |
US4585774A (en) * | 1981-05-08 | 1986-04-29 | Otsuka Pharmaceutical Co., Ltd. | Aniline derivatives and cardiotonic composition |
PH19166A (en) * | 1982-09-04 | 1986-01-16 | Pfizer | Dihydropyridined,pharmaceutical compositions and method of use |
FR2534580A1 (en) * | 1982-10-13 | 1984-04-20 | Synthelabo | PHENYL-1 PIPERIDINO-2 PROPANOL DERIVATIVES, THEIR PREPARATION, AND MEDICINES THAT CONTAIN THEM |
DK623586A (en) * | 1985-12-27 | 1987-06-28 | Eisai Co Ltd | PIPERIDE INGREDIENTS OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE COMPOUNDS |
US4868181A (en) * | 1986-08-04 | 1989-09-19 | E. I. Du Pont De Nemours And Company | 1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity |
KR910006138B1 (en) * | 1986-09-30 | 1991-08-16 | 에자이 가부시끼가이샤 | Cyclic amine derivatives |
EP0294183B1 (en) * | 1987-06-02 | 1994-03-30 | Ajinomoto Co., Inc. | Use of ethylamine derivatives as antihypertensive agents |
DE3852551T2 (en) * | 1987-12-11 | 1995-05-18 | Mitsui Petrochemical Ind | AMINES AND THEIR USE. |
SU1731048A3 (en) * | 1988-05-27 | 1992-04-30 | Эйсай Ко., Лтд (Фирма) | Process for preparing piperidine derivatives of pharmacolocically acceptable salts thereof |
FR2632641B1 (en) * | 1988-06-13 | 1990-10-12 | Irceba | ((ARYL-4-PIPERAZINYL-1) -2 ETHOXY) -3 P-CYMENE, ORTHO DERIVATIVES, META, PARA MONOSUBSTITUTED OR DISUBSTITUTED ON THE PHENYL CORE OF THIS PRODUCT, THE PROCESS FOR THE PREPARATION OF SUCH DERIVATIVES, AND THE MEDICINAL PRODUCTS AS ACTIVE PRINCIPLE |
US5153198A (en) * | 1989-03-15 | 1992-10-06 | Santen Pharmaceutical Co., Ltd. | Agent for treatment of disorders of the cerebro-neural transmission system |
US5116846A (en) * | 1990-03-28 | 1992-05-26 | Du Pont Merck Pharmaceutical Company | N-aralkyl piperidine derivatives as psychotropic drugs |
FR2681319B1 (en) * | 1991-09-12 | 1995-02-17 | Synthelabo | 1- (PHENOXYALKYL) PIPERIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION. |
ES2060547B1 (en) * | 1992-06-04 | 1995-06-16 | Ferrer Int | IMPROVEMENTS IN THE PURPOSE OF THE INVENTION PATENT N / 9201158 THAT REFERS TO "PROCEDURE FOR OBTAINING NEW DERIVATIVES OF 4-BENCILPIPERIDINE". |
FR2705343B1 (en) * | 1993-05-17 | 1995-07-21 | Fournier Ind & Sante | Beta, beta-dimethyl-4-piperidineethanamine derivatives, process for their preparation and their use in therapy. |
-
1994
- 1994-03-24 DE DE4410822A patent/DE4410822A1/en not_active Withdrawn
-
1995
- 1995-03-23 JP JP7524306A patent/JPH09510460A/en active Pending
- 1995-03-23 CA CA002186010A patent/CA2186010A1/en not_active Abandoned
- 1995-03-23 IL IL11310395A patent/IL113103A0/en unknown
- 1995-03-23 AU AU22125/95A patent/AU2212595A/en not_active Abandoned
- 1995-03-23 CZ CZ962770A patent/CZ277096A3/en unknown
- 1995-03-23 KR KR1019960705269A patent/KR970701695A/en not_active Application Discontinuation
- 1995-03-23 EP EP95915116A patent/EP0751936A1/en not_active Withdrawn
- 1995-03-23 HU HU9602607A patent/HUT75653A/en unknown
- 1995-03-23 WO PCT/DE1995/000442 patent/WO1995025721A1/en not_active Application Discontinuation
- 1995-03-23 SK SK1201-96A patent/SK120196A3/en unknown
- 1995-03-23 PL PL95316382A patent/PL316382A1/en unknown
- 1995-03-23 CN CN95192230A patent/CN1145618A/en active Pending
- 1995-03-25 ZA ZA952431A patent/ZA952431B/en unknown
-
1996
- 1996-09-23 FI FI963786A patent/FI963786A0/en not_active Application Discontinuation
- 1996-09-23 NO NO963984A patent/NO963984L/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN1145618A (en) | 1997-03-19 |
IL113103A0 (en) | 1995-06-29 |
MX9604201A (en) | 1997-12-31 |
SK120196A3 (en) | 1997-10-08 |
DE4410822A1 (en) | 1995-09-28 |
CA2186010A1 (en) | 1995-09-28 |
ZA952431B (en) | 1995-12-19 |
NO963984D0 (en) | 1996-09-23 |
EP0751936A1 (en) | 1997-01-08 |
JPH09510460A (en) | 1997-10-21 |
HUT75653A (en) | 1997-05-28 |
FI963786A (en) | 1996-09-23 |
WO1995025721A1 (en) | 1995-09-28 |
KR970701695A (en) | 1997-04-12 |
AU2212595A (en) | 1995-10-09 |
PL316382A1 (en) | 1997-01-06 |
FI963786A0 (en) | 1996-09-23 |
NO963984L (en) | 1996-09-23 |
CZ277096A3 (en) | 1997-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU9602607D0 (en) | New 1,4-disubstituted piperidine derivatives useful as medicaments acting on the glutamate receptor | |
DE69718026D1 (en) | FLUORED 1,4-DISUBSTITUTED PIPERIDINE DERIVATIVES | |
IL127566A0 (en) | Substituted 6,5-hetero- bicyclic derivatives | |
ZA977652B (en) | Substituted 6,6-hetero-bicyclic derivatives | |
HUP0000434A3 (en) | 1,4-substituted cyclic amine derivatives | |
HK1025963A1 (en) | Substituted 1,2,3,4-tetrahydronaphthalene derivatives | |
HUP9904167A3 (en) | 1,4-disubstituted piperazine and piperidine derivatives, their use and pharmaceutical compositions containing the same | |
IL126070A0 (en) | Substituted 1,2,3,4-tetrahydronaphthalene derivatives | |
AU9256498A (en) | 1,4-disubstituted piperazines | |
ZA977427B (en) | 2,4-disubstituted pyrimidine derivative, process for preparing the same, and a pharmaceutical composition containing the same. | |
AU2793197A (en) | 1,4-disubstituted piperidine derivatives | |
IL134572A0 (en) | Substituted 1,2,3,4,5,6-hexahydro-2,6- methano-3-benzazocine-10-oles, methods for the production and use thereof as medicaments | |
SG70589A1 (en) | 1, 25-Dihydroxy-16, 22, 23-trisdehydro-cholecalciferol derivatives | |
EP0834517A4 (en) | Novel anthracycline derivatives having 4-amino-2,4,6-trideoxy-2-fluoro-mannopyranosyl group | |
ZA976813B (en) | Fluorinep-containing 1,4-disubstituted piperidine derivatives. | |
ZA943036B (en) | 1,4-disubstituted piperidine derivative compounds | |
HU908254D0 (en) | New piperidine- and 1,2,3,6-tetrahydro-pyridine derivatives | |
HU9402902D0 (en) | 1,2-dihydro-2-oxo-3-methyl-sulfonyl-aminomethyl-pyridine derivatives | |
HU210820A9 (en) | 1,2,3,6-tetrahydropyridine derivatives | |
HRP940412A2 (en) | 2,6-diaminopurine derivatives | |
SI0673928T1 (en) | Novel N-(3,4-dichlorophenyl-propyl)-piperidine derivatives as selective human NK3-receptor antagonists | |
SI1015433T1 (en) | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments | |
ZA918076B (en) | 1,2,5,6-tetrahydropyridine oxime derivatives | |
HK1031728A1 (en) | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments. | |
HU9501251D0 (en) | 17,20-epoxy-20-substituted-pregnane derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DFD9 | Temporary protection cancelled due to non-payment of fee |